News

September 16, 2026

Enzyre launched its series B investment round

June 23, 2026

ADAMTS13 activity assay article

June 4, 2026

ISO 13485 recertification

May 18, 2026

Enzyre 10-year anniversary

March 16, 2026

Publication at the Journal of Thrombosis and Haemostasis

December 17, 2025

Articles about EnzySystem HemA acceptance

July 24, 2025

WFH’s letter of support for the EnzySystem project

June 24, 2025

ISTH 2025 Congress

April 30, 2025

Publication at Biosensors & Bioelectronics journal

March 20, 2025

Enzyre attends 12th Venture Summit West

February 27, 2025

Enzyre participates in AHAIC 2025

November 1, 2023

Enzyre Announces Founder and CEO’s Transition

August 8, 2023

Enzyre obtains ISO13485 certification

June 13, 2023

Biotech News article Enzyre (Dutch)

May 1, 2023

Enzyre announces appointment of Marcel van Kasteel as Chairman of the Supervisory Board

December 23, 2022

NTC interview with CEO: Enzyre uses investments to save thousands on healthcare

November 2, 2022

Enzyre closes Series A financing round of EUR 12M to advance pioneering diagnostic technology platform for hemophilia patients

May 4, 2022

Enzyre awarded REACT grant for pilot production line

March 4, 2021

Enzyre announces strategic partnership with Takeda to accelerate development of pioneering diagnostic technology platform for hemophilia patients

January 6, 2021

Enzyre wins Best Blood Coagulation Analysis Product 2020 award!

July 27, 2020

Novalis invests in Enzyre to support development of Enzypad, a breakthrough hand-held diagnostic and monitoring device

December 5, 2019

Takeda and Enzyre to develop diagnostic device allowing hemophilia patients to determine their coagulation status at home

April 30, 2019

Enzyre appoints Dirk Pollet as Chief Executive Officer

March 30, 2018

Opening new Enzyre labs at Noviotech Campus

March 29, 2018

Anneke Sijbers wins award for Enzyre

February 23, 2018

Enzyre on local television